Saliladja, Sabriya T.

HRN: 23-34-10  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/09/2024
CEFUROXIME 250MG/5ML, 50ML SUSPENSION (BOT)
04/09/2024
04/15/2024
PO
2.5ml
BID
UTI
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: